A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers

Local Institution - 303, Melbourne

Local Institution - 602, Seoul

Local Institution - 301, Heidelberg

Local Institution - 601, Seoul

Local Institution - 110, New York

Local Institution - 405, Marseille

Local Institution - 107, Pittsburgh

Local Institution - 504, Madrid

Local Institution - 109, Charlotte

Local Institution - 502, Málaga

Local Institution - 402, Borddeaux Cedex

Local Institution - 105, Birmingham

Local Institution - 501, Salamanca

Local Institution - 404, Nantes

Local Institution - 115, St Louis

Local Institution - 106, Oklahoma City

Local Institution - 403, Rouen

Local Institution - 108, Houston

Local Institution - 103, San Antonio

Rocky Mountain Cancer Centers, LLP [Aurora-COAU], Aurora

Local Institution - 101, Scottsdale

Local Institution - 406, Créteil

Local Institution - 401, Villejuif

Local Institution - 112, Sacramento

Local Institution - 113, Portland

Local Institution - 102, Nashville

Local Institution - 201, Edmonton

Local Institution - 202, Toronto

Local Institution - 604, Seoul

Local Institution - 603, Seoul

Local Institution - 802, Manchester